Evidence map›Paper›PMID 36000846›Full record

ArticleJournal of virology2022

N-Linked Glycans Shape Skin Immune Responses during Arthritis and Myositis after Intradermal Infection with Ross River Virus.

Kothila Tharmarajah, Arun Everest-Dass, Jelena Vider, Xiang Liu, Joseph R Freitas, Helen Mostafavi, Jayaram Bettadapura, Mark von Itzstein, Nicholas P West, Adam Taylor and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Glycosylation of GETV E2 promotes pathogenesis in animal models.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Ly6CCell reports · 2024
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Kothila TharmarajahEmerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.
Arun Everest-DassInstitute for Glycomics, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.
Jelena ViderSchool of Pharmacy and Medical Sciences, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.
Xiang LiuEmerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.
Joseph R FreitasEmerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.
Helen MostafaviEmerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.
Jayaram BettadapuraEmerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.
Mark von ItzsteinInstitute for Glycomics, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.ORCID 0000-0001-6302-7524
Nicholas P WestSchool of Pharmacy and Medical Sciences, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.
Adam TaylorEmerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.ORCID 0000-0002-7159-3961
Suresh MahalingamEmerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.ORCID 0000-0003-3141-8410
Ali ZaidEmerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.ORCID 0000-0002-2528-2783
Griffith University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arthritogenic alphaviruses are mosquito-borne arboviruses that include several re-emerging human pathogens, including the chikungunya (CHIKV), Ross River (RRV), Mayaro (MAYV), and o'nyong-nyong (ONNV) virus. Arboviruses are transmitted via a mosquito bite to the skin. Herein, we describe intradermal RRV infection in a mouse model that replicates the arthritis and myositis seen in humans with Ross River virus disease (RRVD). We show that skin infection with RRV results in the recruitment of inflammatory monocytes and neutrophils, which together with dendritic cells migrate to draining lymph nodes (LN) of the skin. Neutrophils and monocytes are productively infected and traffic virus from the skin to LN. We show that viral envelope N-linked glycosylation is a key determinant of skin immune responses and disease severity. RRV grown in mammalian cells elicited robust early antiviral responses in the skin, while RRV grown in mosquito cells stimulated poorer early antiviral responses. We used glycan mass spectrometry to characterize the glycan profile of mosquito and mammalian cell-derived RRV, showing deglycosylation of the RRV E2 glycoprotein is associated with curtailed skin immune responses and reduced disease following intradermal infection. Altogether, our findings demonstrate skin infection with an arthritogenic alphavirus leads to musculoskeletal disease and envelope glycoprotein glycosylation shapes disease outcome.

Indexed as

Alphavirus InfectionsArthritisMyositisPolysaccharidesRoss River virusSkinAnimalsAntiviral AgentsCulicidaeDendritic CellsDisease Models, AnimalGlycosylationHumansMass SpectrometryMiceMonocytesAntiviral AgentsPolysaccharidesViral Envelope ProteinsalphavirusarbovirusesglycanglycosylationinflammationRoss River virusskin immunityskin infection

Identifiers

PMID36000846
PMCPMC9472629
OpenAlexW4293212240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.